Cases & Deals

Myriad acts in High Court's first consideration of genetic material patents

Clients Myriad Genetics, Inc.

Jones Day acted for Myriad Genetics, Inc. in a landmark Australian case before the High Court of Australia. The case represents the first time an Australian court considered the patentability of genetic material, a case in which Jones Day also acted before the U.S. Supreme Court.

D’Arcy v. Myriad Genetics Inc [2015] HCA 35

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.